Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.

Objective: To provide first data on inpatient costs and cost-driving factors due to nonrefractory status epilepticus (NSE), refractory status epilepticus (RSE), and super-refractory status epilepticus (SRSE).

Methods: In 2013 and 2014, all adult patients treated due to status epilepticus (SE) at the university hospitals in Frankfurt, Greifswald, and Marburg were analyzed for healthcare utilization.

Results: We evaluated 341 admissions in 316 patients (65.